ETR vs TRDA · P/E 28, rev $12.95B vs P/E 12, rev $210.8M
Entergy Corporation (ETR) versus Entrada Therapeutics Inc (TRDA) — a side-by-side from cached financials, not a winner call.
Entergy Corporation (ETR) is a utilities - regulated electric company listed on US.
Entrada Therapeutics Inc (TRDA) is a biotechnology company listed on US.
Latest reported ETR revenue for 2025-12-31 was $12.95B. Net income was $1.77B. Revenue was up 9.0% from 2024-12-31 to 2025-12-31. ETR currently screens at market cap $50.71B and trailing P/E 28.3.
Latest reported TRDA revenue for 2024-12-31 was $210.8M. Net income was $65.6M. Revenue was up 63.4% from 2023-12-31 to 2024-12-31. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
ETR currently screens at market cap $50.71B and trailing P/E 28.3. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
Not investment advice. Open the ETR and TRDA stock pages for the full models.
Not investment advice.